Patent ID: 7645773

Claim:
A compound of the formula (I): wherein: R 1 is benzofuran, cyclopentene, cyclohexene, cycloheptene, benzo[1,3] dioxole, indole or phenyl, wherein said phenyl is unsubstituted or mono-, bi-, or tri-substituted independently with halogen, lower alkyl, halo-lower-alkyl, phenyl, —OCH 3 , —O(CH 2 )nCH 3 , —(CH 2 )nOH, —OH, —NH 2 , —OCF 3 , —O(CH 2 )n-phenyl, —SCH 3 , —NHSO 2 CH 3 , thiophene, morpholine, —C(O)CH 3 , —N(CH 3 ) 2 or —NO 2 ; one of R 2 or R 3 is cyclohexane and the other is alkyl or allyl, or R 2 and R 3 , together with the N atom to which they are attached, is decahydroguinoline, azocane, azepane, pipendine, morpholine, adamantane, thiomorpholine, cyclooctane, cyclohepane, pyrrolidine, decahydroisoauinoline, azepane-4-one, hydroxyadaman-ylamine, azabicyclo[3.2.2.]nonane, bicycle[2.2.1]hept-2-ylamine, hexahydro[3.2-c]quinoline, bicycle[3.1.1]heptane or azabicyclo[3.2.1]octane; or a pharmaceutically acceptable salt thereof, with the proviso that the following compounds are excluded: [2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-thiazol-4-yl]-pyrrolidin-1-yl-methanone; [2-(2,3-Dihydro-benzo[1,4]dioxin-2-yl)-thiazol-4-yl]-morpholin-4-yl-methanone; (4-Phenyl-3,6-dihydro-2H-pyridin-1-yl)-(2-phenyl-thiazol-4-yl)-methanone; (2-Benzo[1,2,5]oxadiazol-5-yl-thiazol-4-yl)-morpholin-4-yl-methanone; Morpholin-4-yl-(2-pyridin-3-yl-thiazol-4-yl)-methanone [2-(4-Methyl-pyridin-3-yl)-thiazol-4-yl]-pipendin-1-yl-methanone; [2-(4-Methyl-pyridin-3-yl)-thiazol-4-yl]-morpholin-4-yl-methanone; [2-(5-Methyl-isoxazol-3-yl)-thiazol-4-yl]-pipendin-1-yl-methanone; and [2-(3-Methyl-5-trifluoromethyl-pyrazol-1-yl)-thiazol-4-yl]-morpholin-4-yl-methanone.